Abenes, Arlyn C.

HRN: 00-10-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2023
CEFUROXIME 500MG (TAB)
06/27/2023
07/04/2023
PO
500mg
BID X 7 Days
G1P1 (1001) S/P NSVD; Thinly Meconium Stained Amniotic Fluid
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: